Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shelly C Lu

Showing results (21-30 of 218) with videos related to

Pageof 22
Sort By:
Molecular Pharmacology|January 31, 2008
Epigallocatechin-3-gallate inhibits growth of activated hepatic stellate cells by enhancing the capacity of glutathione synthesisYumei Fu, Shizhong Zheng, Shelly C Lu, et al.
Journal of Gastroenterology and Hepatology|April 11, 2008
Alcohol, cofactors and the genetics of hepatocellular carcinomaMimi C Yu, Jian-Min Yuan, Shelly C Lu
Cancers|September 26, 2020
Hepatocellular Carcinoma: Updates in Pathogenesis, Detection and TreatmentMaria L Martínez-Chantar, Matias A Avila, Shelly C Lu
The Biochemical Journal|May 14, 2005
Cloning and characterization of the human glutathione synthetase 5'-flanking regionTaunia D Lee, Heping Yang, Janet Whang, et al.
Proteomics. Clinical Applications|December 8, 2010
Sub-proteome approach to the knowledge of liverJuan M Falcón-Pérez, Shelly C Lu, José M Mato
Journal of Gastroenterology and Hepatology|September 9, 2006
Methionine adenosyltransferase and S-adenosylmethionine in alcoholic liver diseaseShelly C Lu, M Luz Martínez-Chantar, José M Mato
Annals of Hepatology|February 12, 2013
S-adenosylmethionine metabolism and liver diseaseJosé M Mato, M Luz Martínez-Chantar, Shelly C Lu
Annual Review of Nutrition|March 12, 2008
Methionine metabolism and liver diseaseJosé M Mato, M Luz Martínez-Chantar, Shelly C Lu
World Journal of Gastroenterology|July 12, 2019
Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver diseaseJosé M Mato, Cristina Alonso, Mazen Noureddin, et al.
Hepatology (Baltimore, Md.)|January 23, 2014
Systems biology for hepatologistsJosé M Mato, M Luz Martínez-Chantar, Shelly C Lu
Pageof 22

Showing results (21-30 of 218) with videos related to

Sort By:
Pageof 22
Molecular Pharmacology|January 31, 2008
Epigallocatechin-3-gallate inhibits growth of activated hepatic stellate cells by enhancing the capacity of glutathione synthesisYumei Fu, Shizhong Zheng, Shelly C Lu, et al.
Journal of Gastroenterology and Hepatology|April 11, 2008
Alcohol, cofactors and the genetics of hepatocellular carcinomaMimi C Yu, Jian-Min Yuan, Shelly C Lu
Cancers|September 26, 2020
Hepatocellular Carcinoma: Updates in Pathogenesis, Detection and TreatmentMaria L Martínez-Chantar, Matias A Avila, Shelly C Lu
The Biochemical Journal|May 14, 2005
Cloning and characterization of the human glutathione synthetase 5'-flanking regionTaunia D Lee, Heping Yang, Janet Whang, et al.
Proteomics. Clinical Applications|December 8, 2010
Sub-proteome approach to the knowledge of liverJuan M Falcón-Pérez, Shelly C Lu, José M Mato
Journal of Gastroenterology and Hepatology|September 9, 2006
Methionine adenosyltransferase and S-adenosylmethionine in alcoholic liver diseaseShelly C Lu, M Luz Martínez-Chantar, José M Mato
Annals of Hepatology|February 12, 2013
S-adenosylmethionine metabolism and liver diseaseJosé M Mato, M Luz Martínez-Chantar, Shelly C Lu
Annual Review of Nutrition|March 12, 2008
Methionine metabolism and liver diseaseJosé M Mato, M Luz Martínez-Chantar, Shelly C Lu
World Journal of Gastroenterology|July 12, 2019
Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver diseaseJosé M Mato, Cristina Alonso, Mazen Noureddin, et al.
Hepatology (Baltimore, Md.)|January 23, 2014
Systems biology for hepatologistsJosé M Mato, M Luz Martínez-Chantar, Shelly C Lu
Pageof 22